Schonfeld Strategic Advisors LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 34 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$2,389
+1.4%
33,373
-7.3%
0.00%
Q2 2023$2,356
+63.5%
36,0000.0%0.00%
Q1 2023$1,441
-7.2%
36,0000.0%0.00%
Q4 2022$1,552
-48.3%
36,0000.0%0.00%
Q3 2022$3,000
-25.0%
36,0000.0%0.00%
Q2 2022$4,000
-50.0%
36,0000.0%0.00%
Q1 2022$8,000
-46.7%
36,0000.0%0.00%
Q4 2021$15,00036,0000.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2021
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,636,0000.09%
Telemetry Investments, L.L.C. 121,614$23,0000.04%
Radcliffe Capital Management, L.P. 150,000$1,501,0000.03%
Q Global Advisors, LLC 170,785$37,0000.02%
CANTOR FITZGERALD, L. P. 363,548$79,0000.01%
Atalaya Capital Management LP 225,000$50,0000.01%
MMCAP International Inc. SPC 375,000$82,0000.01%
Bulldog Investors, LLP 54,745$11,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 108,741$24,0000.00%
Context Capital Management, LLC 200,000$44,0000.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders